Seres Therapeutics to Participate in the Piper Sandler 35th Annual Healthcare Conference on Wednesday, November 29, 2023; Webcast at 3:30 p.m. ET
Seres Therapeutics, ticker symbol MCRB, will participate in the Piper Sandler 35th Annual Healthcare Conference on November 29, 2023, at 3:30 p.m. ET. The audio webcast will be available on the company's website, with a replay accessible for 30 days.
11/28/2023 - 09:18 AM
CAMBRIDGE, Mass. --(BUSINESS WIRE)--
Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today announced that Seres management will participate at the Piper Sandler 35th Annual Healthcare Conference on Wednesday, November 29, 2023, at 3:30 p.m. ET.
An audio webcast of the presentation will be available under the “Investors and News” section of Seres’ website. A replay of the presentation will become available approximately one hour after the event and will be archived for approximately 30 days.
About Seres Therapeutics
Seres Therapeutics, Inc. (Nasdaq: MCRB) is a commercial-stage company developing novel microbiome therapeutics for serious diseases. Seres’ lead program, VOWST™, obtained U.S. FDA approval in April 2023 as the first orally administered microbiome therapeutic to prevent recurrence of C. difficile infection (CDI) in adults following antibacterial treatment for recurrent CDI and is being commercialized in collaboration with Nestlé Health Science. Seres is evaluating SER-155 in a Phase 1b study in patients receiving allogeneic hematopoietic stem cell transplantation. For more information, please visit www.serestherapeutics.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20231127059541/en/
Investor and Media:
kmannix@serestherapeutics.com
Source: Seres Therapeutics, Inc.
What is the date of the Piper Sandler 35th Annual Healthcare Conference where Seres Therapeutics will participate?
Seres Therapeutics will participate in the Piper Sandler 35th Annual Healthcare Conference on November 29, 2023.
Where can I access the audio webcast of Seres Therapeutics' presentation at the conference?
The audio webcast of the presentation will be available under the 'Investors and News' section of Seres' website.
How long will the replay of the presentation be available?
A replay of the presentation will be available approximately one hour after the event and will be archived for approximately 30 days.
MCRB Rankings
#5388 Ranked by Stock Gains
MCRB Stock Data
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Tags
Health Technology, Biotechnology, Manufacturing, Pharmaceutical Preparation Manufacturing
Country
US
City
Cambridge
About MCRB
seres therapeutics is a clinical stage biotherapeutic company focused on discovering and developing ecobiotic™ therapeutic products, novel drugs to treat important diseases by targeting the underlying biology of the human microbiome. founded by flagship venturelabs, seres is pioneering the first therapeutics that catalyze a shift to health by augmenting the biology of the microbiome. current candidates span infectious, metabolic, and inflammatory diseases. for more information, please visit http://serestherapeutics.com/.
